Contrarily, modulation of the SIRT3/FOXO1 pathway through salvianolic acid B was shown to improve NAFLD in rats, by reducing oxidative stress [362]. This evidence concerns the gene SIRT3 and metabolic dysfunction-associated steatotic liver disease.